Key facts
| Item | Details |
|---|---|
| Active ingredient | Semaglutide (GLP-1 receptor agonist) |
| Maker | Novo Nordisk |
| Forms | Weekly pen (0.25–2.4 mg), Wegovy HD pen (7.2 mg), daily pill (1.5, 4, 9, 25 mg) |
| FDA-approved uses | Chronic weight management in adults and children 12+ with obesity, or adults with overweight and a weight-related condition; reducing cardiovascular risk in adults with heart disease and obesity or overweight; adults with noncirrhotic MASH with moderate to advanced liver fibrosis |
| Self-pay price (NovoCare) | Pen $349/mo ($199 for the first 2 fills at the lowest doses); HD $399/mo; pill $149–$299/mo by dose |
FDA approval timeline
| Date | Milestone |
|---|---|
| June 2021 | Approved for chronic weight management |
| March 2024 | Approved to reduce cardiovascular risk |
| August 2025 | Accelerated approval for noncirrhotic MASH |
| December 2025 | Wegovy pill approved; US launch January 2026 |
| March 2026 | Wegovy HD 7.2 mg approved |
What the trials found
In the STEP 1 trial, adults on Wegovy 2.4 mg lost about 15% of body weight on average over 68 weeks, compared with about 2–3% on placebo. In the STEP UP trial, the 7.2 mg dose produced about 19–21% average weight loss over 72 weeks, depending on how results were measured. In OASIS 4, the 25 mg pill produced about 14% average weight loss (about 17% in people who kept taking it). These are trial averages, not a promise of individual results.
Side effects and warnings
The most common side effects in trials were nausea, diarrhea, vomiting, constipation and stomach pain. The label carries a boxed warning about thyroid C-cell tumors seen in rodents, and Wegovy is not for people with a personal or family history of medullary thyroid cancer or MEN2. See our side effects guide.
Where to get Wegovy
Wegovy needs a prescription. Telehealth programs we review that list it:
| Provider | Typical price | Our score |
|---|---|---|
| Ro Body Program | From ~$448/mo all-in (Wegovy pill) | Our score: 9.3/10 |
| Hims & Hers Weight Loss | From ~$448/mo all-in (Wegovy pill) | Our score: 9.0/10 |
| Found | From ~$289/mo | Our score: 8.6/10 |
| BiltRx | Compounded semaglutide from $81/mo; tirzepatide from $129/mo (+ consult and shipping) | Our score: 8.4/10 |
| GoodRx for Weight Loss | From ~$338/mo all-in (Wegovy pill) | Our score: 8.4/10 |
| WeightWatchers Clinic | ~$373/mo after intro month | Our score: 8.2/10 |
Compare prices in our tracker → · Estimate your monthly cost →
Compounded GLP-1s are not FDA-approved. They are not equivalent to Wegovy. Which medication, if any, is suitable is decided by a licensed clinician.
FAQ
What is Wegovy?
Wegovy is a brand-name prescription medicine made by Novo Nordisk. Its active ingredient is semaglutide.
Is compounded semaglutide the same as Wegovy?
No. Compounded semaglutide is not FDA-approved and is not equivalent to Wegovy. The FDA does not review compounded drugs for safety, effectiveness or quality.
How do I get Wegovy?
Wegovy requires a prescription from a licensed clinician, who decides whether it is suitable for you. Prescriptions can be filled at retail pharmacies, through telehealth programs or at the manufacturer's self-pay pharmacy.
Related guides
- Wegovy vs Ozempic: Why two semaglutide brands exist, how their doses and approved uses differ, and what each costs to self-pay.
- GLP-1 pills compared: The two FDA-approved weight-loss pills compared on dosing, results, price and how to get them.
- Semaglutide vs tirzepatide: How Wegovy and Zepbound differ in how they work, results, side effects and price.
- LillyDirect vs NovoCare: How Eli Lilly's and Novo Nordisk's self-pay pharmacies work, what they charge by dose and what you need to order.
Sources
- Wegovy prescribing information
- Wilding et al., STEP 1, NEJM 2021
- STEP UP results (Drugs.com)
- Fierce Pharma: Wegovy pill launch and OASIS 4
- AACE: Wegovy approved for MASH
- NovoCare: Wegovy cost
GLP1Rated is for general information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects. Talk to a licensed clinician before starting, stopping or changing any medication or supplement.